| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 12 | +50.00% | -0.64% | -0.49% | -0.14% | -0.18% | — |
| 14d | 12 | +66.67% | -2.84% | -1.46% | -1.38% | -4.46% | — |
| 30d | 12 | +83.33% | +3.12% | -1.52% | +4.65% | -5.84% | — |
| 60d | 12 | +58.33% | +15.30% | +0.87% | +14.43% | +1.77% | — |
| 90d | 12 | +25.00% | +11.15% | +2.12% | +1.31% | -0.03% | — |
| 180d | 12(4 pending) | +75.00% | -23.32% | +8.18% | -31.50% | -45.28% | — |
| 1y | 12(4 pending) | +100.00% | -26.78% | +19.42% | -46.19% | -44.74% | — |
| 2y | 12(12 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 43,246 | $13.77 | $595.7K | 72,832 | Mar 5, 2026 | Mar 5, 2026 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 5,377 | $13.31 | $71.5K | 116,078 | Mar 4, 2026 | Mar 5, 2026 ↗ | View → |
| NVCR NOVOCURE LTD | PURCHASEGRANT Stock grant | 58,488 | — | — | 66,006 | Mar 3, 2026 | Mar 5, 2026 ↗ | View → |
| NVCR NOVOCURE LTD | PURCHASEGRANT Stock grant | 45,112 | — | — | 121,455 | Mar 3, 2026 | Mar 5, 2026 ↗ | View → |
| NVCR NOVOCURE LTD | PURCHASEGRANT Stock grant | 7,518 | — | — | 7,518 | Mar 3, 2026 | Mar 5, 2026 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 408 | $13.49 | $5.5K | 76,343 | Mar 2, 2026 | Mar 3, 2026 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 1,555 | $13.66 | $21.2K | 76,751 | Feb 27, 2026 | Mar 3, 2026 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 2,133 | $14.35 | $30.6K | 78,306 | Jan 11, 2026 | Jan 12, 2026 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 2,949 | $12.23 | $36.1K | 80,439 | Nov 4, 2025 | Nov 4, 2025 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 168 | $12.81 | $2.2K | 83,388 | Nov 1, 2025 | Nov 4, 2025 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 592 | $17.91 | $10.6K | 83,556 | May 3, 2025 | May 5, 2025 ↗ | View → |
| NVCR NOVOCURE LTD | PURCHASEGRANT Stock grant | 54,975 | $18.19 | $1000.0K | 84,148 | Mar 4, 2025 | Mar 6, 2025 ↗ | View → |
| NVCR NOVOCURE LTD | PURCHASEGRANT Stock grant | 81,499 | $18.19 | $1.48M | 81,499 | Mar 4, 2025 | Mar 6, 2025 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 250 | $18.54 | $4.6K | 29,173 | Mar 3, 2025 | Mar 4, 2025 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 368 | $18.28 | $6.7K | 29,423 | Feb 28, 2025 | Mar 3, 2025 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 368 | $18.28 | $6.7K | 29,423 | Feb 28, 2025 | Mar 3, 2025 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 1,379 | $19.92 | $27.5K | 30,058 | Feb 27, 2025 | Mar 3, 2025 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 267 | $20.55 | $5.5K | 29,791 | Feb 27, 2025 | Mar 3, 2025 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 267 | $20.55 | $5.5K | 29,791 | Feb 27, 2025 | Mar 3, 2025 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 1,379 | $19.92 | $27.5K | 30,058 | Feb 27, 2025 | Mar 3, 2025 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 2,160 | $26.81 | $57.9K | 31,437 | Jan 11, 2025 | Jan 15, 2025 ↗ | View → |
| NVCR NOVOCURE LTD | PURCHASEGRANT Stock grant | 30,138 | — | — | 33,597 | Nov 4, 2024 | Nov 6, 2024 ↗ | View → |
| NVCR NOVOCURE LTD | PURCHASEGRANT Stock grant | 45,620 | $16.59 | $756.8K | 45,620 | Nov 4, 2024 | Nov 6, 2024 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 44 | $16.69 | $734 | 3,459 | Nov 2, 2024 | Nov 6, 2024 ↗ | View → |
| NVCR NOVOCURE LTD | SALE Chief Operating Officer | 160 | $15.88 | $2.5K | 3,503 | Nov 1, 2024 | Nov 4, 2024 ↗ | View → |